Download - THYROID CARCINOMA
![Page 1: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/1.jpg)
أيها ـ برٱستعينوا ءامنوا ٱلذيني ةوٱلصبٱلص إنلو برينمعٱلل ـ ٱلص
O you who believe! Seek help in patience and
As-Salât (the prayer). Truly! Allâh is with As-
Sâbirun (the patient.) (153)
![Page 2: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/2.jpg)
Approach to thyroid CA
![Page 3: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/3.jpg)
Approach to thyroid cancer● Papillary thyroid
cancer(PTC)
● Follicular thyroid cancer(FTC)
● Anaplastic thyroid cancer(ATC)
● Medullary thyroid cancer(MTC)
![Page 4: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/4.jpg)
Epidemiology
● Incidence is 9 cases/100000 persons per year
● 90-95 % are PTC and FTC
● More common in female
![Page 5: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/5.jpg)
Risk factors
● External head and neck radiation
● Family H/O of thyroid cancer/MEN -2
● Iodine deficiency
![Page 6: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/6.jpg)
Clinical diagnosis● Thyroid nodule
● Incidentaloma
● Cervical lymphadenopathy
![Page 7: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/7.jpg)
Obstructive symptoms● Dysphagia
● Hoarseness
● Dyspnea
![Page 8: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/8.jpg)
Other symptoms● Metastasis to lung and
bone
● ATC presents as rapidly enlarging thyroid mass
![Page 9: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/9.jpg)
MTC ● ACTH
● Calcitonin
![Page 10: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/10.jpg)
D/D● Solitary thyroid nodule
● Multinodular goiter
● Cyst
● Thyroiditis
![Page 11: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/11.jpg)
Diagnosis approach● FNAC
● Surgical pathology
![Page 12: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/12.jpg)
Laboratory tests
● TSH
● Thyroglobulin-
● Calcitonin
![Page 13: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/13.jpg)
USG neck● Accurate needle placement
● Potential metastatic lymph node
● Planning nodal dissection
● Identification of recurrent disease
![Page 14: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/14.jpg)
Thyroid ultrasound of a nonpalpable recurrent papillary thyroid carcinoma
![Page 15: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/15.jpg)
Radioactive whole body scan
● To identify recurrent/residual disease
● To identify bone and soft tissue metastasis
![Page 16: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/16.jpg)
CT/MRI neck● Identify soft tissue extension
● Cervical lymph node metastasis
![Page 17: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/17.jpg)
PET scan● To identify sites of distant
metastases
![Page 18: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/18.jpg)
FNAC● Accurately detects PTC
● May not distinguish between benign and malignant follicular lesions
![Page 19: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/19.jpg)
Papillary thyroid cancer: Findings on FNAC
![Page 20: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/20.jpg)
Treatment modalities● Surgery
● L-thyroxin
● Radioiodine treatment
● Chemotherapy
● External beam radiation
![Page 21: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/21.jpg)
Near total thyroidectomy● Age <15 >45
● History of radiation
● Known distant metastasis
● B/L disease
● Extrathyroid invasion
● Tumour size >4 cm
● Cervical lymph node metastases
● Family H/O of thyroid CA
![Page 22: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/22.jpg)
Lobectomy
Stage I disease
![Page 23: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/23.jpg)
Lobectomy
Advantages
• Low risk of hypoparathyroidism
• Low risk of hypothyroidism
• Low risk of injuring recurrent laryngeal nerve
Disadvantages
• Inability to monitor for residual/recurrent disease with thyroglobulin
![Page 24: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/24.jpg)
TSH suppression therapy● Low risk of recurrence TSH should be
suppressed to low but detectable range
● High risk of recurrence or with known distant metastasis complete suppression is indicated
● Most patients with stage I PTC/primary tumors<1.5cm
![Page 25: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/25.jpg)
Radioactive iodine● Post surgical ablation of residual
thyroid tissue
● Treatment of residual or recurrent thyroid cancer
![Page 26: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/26.jpg)
Indication for radioactive iodine treatment● Larger papillary carcinomas
● FTC
● Evidence of metastases
![Page 27: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/27.jpg)
External beam radiotherapy● Treatment of specific
metastatic lesion
![Page 28: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/28.jpg)
ATC and other forms of thyroid cancer● Multimodal therapy may be
beneficial
● Radioactive iodine can be used if there is residual uptake
● Palliative chemotherapy can be used
![Page 29: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/29.jpg)
MTC● Surgical excision
● External beam radiation can be used for local metastases in neck
● Palliative chemotherapy
![Page 30: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/30.jpg)
Ongoing care● TSH suppression therapy
![Page 31: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/31.jpg)
Monitoring for recurrence● Iodine 131 /whole body scan or
thyroid USG
● Measurement of serum Tg
![Page 32: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/32.jpg)
Surveillance● Physical examination every 3-6
months for 2 years and then annually if disease free
● TSh and Tg at 6 and 12 months and then annually if disease free
● Radioiodine scan every year until 1 negative scan
![Page 33: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/33.jpg)
MTC monitoring● Annual measurement of
calcitonin and CEA
● Periodic USG
● Octreotide scan to localise metastatic lesion
![Page 34: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/34.jpg)
Take home message
● PTC and FTC are most common
● USG guided FNAC is diagnostic
● Surgery can be almost curative
● Needs long term F/U
![Page 35: THYROID CARCINOMA](https://reader034.vdocuments.mx/reader034/viewer/2022042607/55a732691a28ab70028b472c/html5/thumbnails/35.jpg)
References
Uptodate 2015
Harrisons principles of internal
medicine